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Abstract 
The present study aimed to confirm the requirement for dietary phospholipid in Atlantic 
salmon and better define the level and period of requirement. Thus, the effects of dietary 
supplementation with phospholipid supplied by krill or soy lecithin were investigated in 
Atlantic salmon, Salmo salar. First feeding fry were fed diets containing 55 % protein and 17 
% lipid supplemented with krill oil or soybean lecithin in a regression design at five levels, 
1.5 (unsupplemented), 2.6, 3.2, 3.6 and 4.2 % total phospholipid and fish were sampled at 1 g 
(1400 ˚day post fertilisation, dpf), 2.5 g (1990 ˚dpf), 5 g (2350 ˚dpf), 10-20 g (2850 ˚dpf) and 
smolt (3800 ˚dpf). Survival was high overall with a positive correlation  (r2 = 0.59 - 0.72) 
between survival and dietary phospholipid supplementation. Growth was improved by 
phospholipid with highest growth achieved in fish fed krill phospholipid at 2.6 % and in fish 
fed soy lecithin at 3.6 %. The pattern of growth differed between fish up to 2.5 g and that 
from 2.5 g onwards with SGR (0-2.5 g) being significantly higher in fish fed 2.6 % krill 
phospholipid and 3.6 % soy phospholipid compared to the basal diet, whereas there was no 
difference in SGR (2.5g-smolt) between the treatments. Intestinal steatosis was observed in 
2.5 g fish fed the unsupplemented diet (20 % prevalence) and lower levels of soy (10 % 
prevalence), whereas it was absent from 2.5 g fish fed krill oil and higher levels of soy 
lecithin (≥ 3.2 %), and fish at all later stages. Prevalence of vertebral deformities was low but 
was reduced by increasing dietary phospholipid with krill oil generally being more effective. 
The results were consistent with salmon having a dietary requirement for dietary phospholipid 
in early life stages. 
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1. Introduction 
 Since the first report of a dietary phospholipid requirement in an aquatic organism, 
specifically shrimp (Teshima et al., 1982), it has become well established that inclusion of 
intact phospholipids in the diet can improve culture performance of various freshwater and 
marine fish species (Coutteau et al., 1997). The primary criteria used to define the beneficial 
effects of dietary phospholipid have been growth and survival, but effects on development 
and stress resistance have also been reported in some species (Coutteau et al., 1997; Cahu et 
al., 2003b). Phospholipid requirement appears to be restricted to early life stages and so the 
specific evidence supporting a requirement for dietary intact phospholipid in fish has been 
improved growth in both larvae and early juveniles, increased survival rates and decreased 
incidence of malformation in larvae, and perhaps increased stress resistance (Tocher et al., 
2008). However, no requirement has been established in adult fish of any species, although 
this has been largely unstudied (Tocher et al., 2008). In Atlantic salmon (Salmo salar), a 
requirement for dietary phospholipid based on growth performance was demonstrated in 
Atlantic salmon of 0.18 g, 1.0 g and 1.7 g initial weight, whereas in fish of 7.5 g initial 
weight, no requirement was observed (Poston, 1990). Dietary supplementation with lecithin 
also improved survival of 0.18 g fish but not of larger fish (Poston, 1990). 
    Most commonly, the levels of phospholipid requirement can vary depending upon species 
and developmental stage (larvae or juveniles) from around 2 % up to much higher levels of 12 
- 14 % of diet (Cahu et al., 2003a; Rinchard et al., 2007). In Atlantic salmon, growth rate was 
higher in fry of initial weight 0.18 g, 1 g or 1.7 g fed soy lecithin at 4 % of diet compared to 
fish fed the basal, unsupplemented feed (Poston, 1990). The phospholipid content of the food-
grade lecithin used was unclear but may have been around 60 %, which means the growth 
enhancement was obtained by supplementing the diet with 2.4 % phospholipid. In a later trial, 
graded levels of feed-grade lecithin (an approximately 1:1 mix of soy and corn lecithin) were 
tested in 0.18 g first-feeding salmon fry and a supplementation level of 6 % provided the 
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highest growth rate (Poston, 1991). Again the precise phospholipid content of the lecithin 
mixture used was not clear but appeared generally similar to food-grade lecithin used 
previously although it was also reported as being around 90 % as “nutritionally effective” as 
crude soy lecithin (Poston, 1991). Therefore, supplementation with 6 % feed grade lecithin 
may represent somewhere between 3.2 and 3.6 % dietary phospholipid. 
     Based on a few studies where semi-purified phospholipid preparations have been used, the 
rank order for efficacy generally appears to be phosphatidylcholine (PC) > 
phosphatidylinositol (PI) > phosphatidylethanolamine (PE) > phosphatidylserine (PS) 
(Kanazawa, 1983, 1993; Kanazawa et al., 1985), with PC being associated with improved 
growth performance whereas PI has been associated with increased survival and reduced 
deformities (Geurden et al., 1998a). The efficacy of other phospholipid classes or 
sphingolipids is not known (Tocher et al., 2008).  In the early studies on Atlantic salmon, the 
phospholipid class compositions of the lecithin preparations used were not assayed or fully 
described although it was reported that soybean lecithin was predominantly PC, PE and PI 
(Poston, 1991) and that the food-grade lecithin used contained around 16 % PC (Poston, 
1990). Extrapolating from this figure would suggest that the growth promoting effect of 
lecithin supplementation was associated with a dietary PC level of around 0.6 to 1.0 %.  
      The mechanism underpinning the role of dietary phospholipids in early life stages of fish 
is not fully understood. The role appears to not be related to the delivery of other essential 
dietary components such as essential fatty acids, phosphate or the bases choline and inositol 
(Tocher et al., 2008). For instance supplemental choline did not replicate the effect of dietary 
soy lecithin in the early studies on Atlantic salmon (Poston, 1990, 1991). However, studies 
showed that phospholipid-deficient diets could lead to the accumulation of lipid 
vacuoles/droplets (steatosis) in enterocytes in fish larvae leading to the suggestion that dietary 
phospholipids may be required for the efficient export of dietary lipids from the intestine 
(Fontagné et al., 1998; Geurden et al., 1998b; Olsen et al., 1999; Salhi et al., 1999; Liu et al., 
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2002). Furthermore, as phospholipid is required for lipoprotein assembly, it was proposed that 
the stimulating effects of phospholipids on growth were due to early life stages of fish having 
limited ability for de novo phospholipid biosynthesis (Geurden et al., 1995, 1999; Fontagné et 
al., 1998). Thus, dietary phospholipids increase the efficiency of transport of dietary fatty 
acids and lipids from the gut to the rest of the body possibly through enhanced lipoprotein 
synthesis (Tocher et al., 2008). 
      Our overall aim is to determine the precise molecular mechanism(s) underpinning the 
requirement for dietary intact phospholipid in fish and so one objective of the present study 
was to provide experimental material for mechanistic studies. Our target species was Atlantic 
salmon due to the fact that, despite the huge commercial importance of this species, its dietary 
requirements are generally poorly studied and largely extrapolated from rainbow trout data 
(NRC, 2011). Dietary phospholipid requirements in Atlantic salmon were last investigated a 
quarter of a century ago in relatively short-term studies (12-16 weeks), using lecithin 
preparations with rather undefined phospholipid content and class composition. Therefore, the 
particular aims of the present study were to confirm the requirement for dietary phospholipid 
in Atlantic salmon, better define the level of requirement, and further establish the period of 
requirement. To this end, Atlantic salmon fry were fed diets containing either krill oil or 
soybean lecithin in a regression design at five levels from first feeding through to parr-smolt 
transformation. Analyses focused on growth, mortality, vertebral malformation and intestinal 
histology (steatosis). 
 
2. Materials and Methods 
To be consistent with previous studies on phospholipid requirements of fish, the term 
“phospholipid” in the present paper will specifically refer to the glycerophospholipids, the 
major classes being PC, PE, PS and PI.  
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2.1 Experimental Diets 
 Diets were formulated and manufactured by BioMar AS (BioMar Tech Centre, 
Brande, Denmark). Commercially available feed ingredients were used and diets were 
formulated to meet the dietary requirements of appropriately sized salmon, including vitamin 
and mineral requirements (NRC, 2011). Prior to use, the lipid class compositions of the 
phospholipid products were analysed (see below). The soybean lecithin (Cargill, Germany) 
was 49 % polar lipids containing 10.4 % PC, 9.2 % PI, 7.5 % PE and 1 % PS, with the 
remaining polar classes being predominantly glycolipids. The neutral lipids (51 %) were 
predominantly triacylglycerol (37 %) with 7 % each of sterols and free fatty acids. The krill 
oil (Aker Biomarine, Norway) was 40 % polar lipids with 26 % PC and 2 % PE with trace 
amounts of PI and PS, with the remaining polar lipids being non-glycerophospholipid (e.g. 
sphingo- and glycolipids) and pigment. The neutral lipids (60 %) contained 30 % 
triacylglycerol with 15 % each of sterols and free fatty acids.  
   A total of nine diets were formulated to deliver target phospholipid levels of basal 
(unsupplemented) and 4 levels each of krill oil or soybean lecithin. The basal diet mix 
contained 400 g kg-1 of fishmeal (Koster Marine Proteins Gmbh, Germany), 100 g kg-1 each 
of soy protein concentrate (Selecta SPC, Brazil), corn gluten (Cargill, Germany) and wheat 
gluten (Vest Korn, Norway), 30 g kg-1 pea protein (R2 Group, Denmark), 80 g kg-1 wheat 
flour (R2 Group), and 64 g kg-1 vitamin/mineral premix (BioMar Premix, Vilomix, Denmark). 
The added oil component of the diet accounted for 126 g kg-1, which was supplied in the basal 
(unsupplemented) feed by a 3:2 mix of fish oil (Peruvian FO, ED&F Man, Germany) and 
rapeseed oil (Emmelev, Denmark). To reach targeted dietary phospholipid levels, krill oil and 
soybean lecithin were included in the formulations, replacing as much as possible fish oil and 
rapeseed oil, respectively, as shown in Table 1. The proximate compositions and the lipid 
class compositions of the nine feeds are shown in Table 2. This shows that the basal, 
unsupplemented feed still delivered 1.5 % phospholipid, with 4 pairs of feeds delivering on 
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average 2.6, 3.2, 3.6 and 4.2 % total phospholipid (sum of PC, PE, PI and PS). The feed 
design aimed to balance dietary fatty acid compositions as much as possible but this was not 
fully successful at the highest inclusion of phospholipid (Table 3). The feeds were all 
produced by extrusion and were fed from first feeding through to smolt with appropriately 
increasing pellet sizes from 0.5 mm. The data presented in Tables 1-3 show mean values for 
the 0.5, 0.8 and 1.1 mm feeds that covered the fish from first feeding to 5 g. 
 
2.2. Experimental fish  
The feeding trial was carried out at the University of Stirling freshwater facilities 
(Niall Bromage Freshwater Research Facility, Stirling, UK) with all experimental procedures 
conducted in compliance with the Animals Scientific Procedures Act 1986 (UK Home Office 
Code of Practice. HMSO: London January 1997) in accordance with EU regulation (EC 
Directive 86/609/EEC) and approved by the Animal Ethics and Welfare Committee of the 
University of Stirling. The stock used was produced from two sea-winter broodstock fish with 
a full five-generation pedigree available from the Landcatch breeding programme (Landcatch 
Natural Selection Ltd, Stirling University Innovation Park, UK). Eyed Atlantic salmon ova 
(380 ˚days) were supplied in January 2012 and randomly distributed (2000 ova / tank) 
between 9 square 1x1m fibreglass hatching tanks (0.3 m3, 10.6 L min-1, O2 > 8 mg L-1) on 
flow-through supplied by spring water at ambient temperature (6.6 ± 0.7 ˚C) and maintained 
in complete darkness under blackout covers until first feeding. At first-feeding (900 ˚day post 
fertilisation, 19 March 2012), fry were maintained under constant light (LL) and water 
temperature increased to 9.5 ± 1.0 ˚C and fed one of 9 experimental diets (one tank per diet) 
according to the manufacturer's tables by clockwork belt feeders over a 24 h period. Tanks 
were flushed once daily, and mortalities recorded twice daily. In mid-May 2012, fry (~ 0.75 
g) were transferred to smolt rearing tanks with each dietary treatment now fed to duplicate 
circular covered fibreglass tanks, each of 2 m diameter (1.6m3, 15 L min-1, O2 > 8 mg L-1), on 
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ambient water temperature, range 1.0 °C (winter) – 15.5 °C (summer). Fish were maintained 
on LL until September 2012 where the photoperiod was changed to simulated natural 
photoperiod (SNP) until completion of smoltification in April 2013, with illumination 
provided by two 28 W fluorescent daylight bulbs (4000 °K, RS Components, UK) positioned 
centrally in the tank lids 0.4 m above the surface. Fish in all tanks were fed continuously 
during the light period by automatic feeders (Arvotec T Drum 3L; Arvotec, Finland) 
controlled by a computer-aided (PC) system. Specific feeding rates (SFR; % tank biomass per 
day) were adjusted automatically according to predicted growth and daily temperature. Fish 
were fed experimental feeds with pellet size increasing from 0.5 mm at start of feeding to 2.0 
mm at smoltification.  
 
2.3 Sampling Procedures 
Environmental parameters and mortality were recorded twice per day for the duration 
of the trial. Fish were sampled for growth at approximately 1 g (1400 ˚day post fertilisation, 
dpf), 2.5 g (1990 ˚dpf), 5 g (2350 ˚dpf), 10-20 g (2850 ˚dpf) and smolt (3800 ˚dpf). At each 
time point 50 fish / tank were anaesthetised (MS222, PHARMAQ, UK), individual weights (± 
0.1 g) and fork lengths (± 1.0 mm) measured, and fish allowed to recover in aerated water 
before returning to experimental tanks. In addition, a total of 5 fish / tank (n = 10 / diet) were 
euthanized by an overdose of MS222, livers and intestine dissected out and stored in 10 % 
neutral buffered formalin or SERRA fixative (ethanol / formalin / acetic acid, 6:3:1 by vol.) 
respectively, for histological analyses (Dapra et al., 2011). A further 30 fish per dietary group 
were euthanized in an overdose of MS222 at termination of the trial and frozen flat on trays at 
−20 °C for later x-ray analysis of spinal deformity. 
 
2.4 Feed analyses  
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Feeds were ground prior to determination of proximate composition according to 
standard procedures (AOAC, 2000). Moisture contents were obtained after drying in an oven 
at 110 °C for 24 h and ash content determined after incineration at 600 °C for 16 h. Crude 
protein content was measured by determining nitrogen content (N×6.25) using automated 
Kjeldahl analysis (Tecator Kjeltec Auto 1030 analyzer, Foss, Warrington, U.K), and crude 
lipid content determined after acid hydrolysis followed by Soxhlet lipid extraction (Tecator 
Soxtec system 2050 Auto Extraction apparatus, Foss, Warrington, U.K). Total lipid was 
extracted by chloroform/methanol (2:1, v/v) and content determined gravimetrically (Folch et 
al., 1957). Lipid class composition of dietary lipid was determined by high performance thin-
layer chromatography (HPTLC) using 10 × 10 cm HPTLC plates (VWR, Lutterworth, 
England) and classes quantified by scanning densitometry using a CAMAG-3 TLC scanner 
(version Firmware 1.14.16) (Henderson and Tocher, 1992). Scanned images were recorded 
automatically and analysed using winCATS Planar Chromatography Manager, version 1.2.0). 
Fatty acid methyl esters (FAME) were prepared from total lipid by acid-catalysed 
transesterification at 50 ˚C for 16 h (Christie, 2003), and FAME extracted and purified as 
described previously (Tocher and Harvie, 1988). FAME were separated and quantified by 
gas-liquid chromatography using a Fisons GC-8160 (Thermo Scientific, Milan, Italy) 
equipped with a 30 m × 0.32 mm i.d. × 0.25 µm ZB-wax column (Phenomenex, Cheshire, 
UK), on-column injector and a flame ionisation detector. Data were collected and processed 
using Chromcard for Windows (version 2.01; Thermoquest Italia S.p.A., Milan, Italy). 
Individual FAME were identified by comparison to known standards and published data 
(Tocher and Harvie, 1988). 
 
2.5 Saltwater Challenge  
  Groups of 10 randomly selected fish from the largest and smallest (by weight) krill or 
soy lecithin dietary groups were subjected to a saltwater challenge at approximately 300 
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(3635 ˚dpf), 400 (3718 ˚dpf), 500 (3872 ˚dpf) and 550 ˚days post-winter solstice. The test was 
conducted for 24 h in 100 L tanks of 10 °C aerated seawater (35 ppt) (Instant Ocean; Animal 
House, Batley, UK). Each diet was stocked into a separate 100 L tank. Following challenge, 
all fish were removed, numbers of surviving fish counted to determine seawater survival, and 
were then culled and blood removed from the caudal vein before centrifugation at 500 g for 
15 min at 4 °C. Serum was collected and stored at −20 °C until analysis of serum chloride 
using a chloride analyser (Sherwood Instruments Inc., UK). Serum samples were analysed in 
triplicate per individual and the average taken of the three technical replicates.  
 
2.6 Histological Analysis 
Serra fluid fixed intestines (n = 10 / treatment, 5 fish/tank) from fry at 2.5g (1990 ˚dpf) 
and parr at 10-20 g (2850 ˚dpf) were measured for enterocyte height, and presence/absence of 
steatosis from the mid-intestine after paraffin wax embedding. Longitudinal sections (4 µm 
thick) were stained with Alcian blue, periodic acid Schiff reagent and Mayer's haematoxylin 
(AB/PAS). For each fish, the height of five apical enterocytes were measured in a randomly 
chosen mid-intestinal fold by image analysis (Abramoff et al., 2004). Enterocyte heights were 
considered as the linear distance between the basal surface and the luminal edge of the brush 
border (passing through the enterocyte nucleus). Additionally, all fish were measured for the 
presence of enterocyte steatosis in the first part of the mid-intestine (i.e. immediately aboral to 
the last pyloric caecum). The term steatosis was applied when clear vacuoles with a diameter 
greater than 5 µm were observed in the enterocytes, and measurement was achieved using a 
three-point scoring system (0 = no hepatocyte vacuolization observed; 1 = mild hepatic 
vacuolization; and 2 = severe hepatocyte vacuolization). 
 
2.7 Spinal Deformity – X Ray Radiography 
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Frozen fish (n = 30 / treatment, 15 fish / tank) were x-radiographed using a portable x-
ray unit (Celtic SMR PX40 HF) with an extremities plate measuring 24 cm x 30 cm. Each 
radiograph was exposed for 32 mAs and 40kV and the image digitized (AGFA CR-35X).  
The radiographs were observed using Adobe Photoshop CS 6 (version 13.0.1, Adobe system 
Incorporated, California, USA) with the spine divided into four sections, regions 1, 2, 3, and 4 
(Kacem et al., 1998) and deformity type categorised according to Witten et al. (2006). 
Observations were made in the anterior-caudal direction. The total number of vertebra was 
recorded for each fish.  
 
2.8 Statistical analysis 
All data are means ± S.D unless otherwise specified. Percentage data were subjected to 
arcsine square-root transformation prior to statistical analyses. Data were tested for normality 
and homogeneity of variances with Levene’s test prior to one-way analysis of variance 
followed by a Tukey-Kramer HSD multiple comparisons of means. Contingency chi-square 
tests were used to compare significant differences between deformed and non-deformed 
vertebrae. All statistical analyses were performed using Minitab software (v16.1, 
Pennsylvania, USA).  
  
3. Results 
3.1 Growth and survival 
 A significant correlation (r2 = 0.59 - 0.72) between increasing dietary phospholipid 
supplementation and decreased mortality was observed with both dietary phospholipid 
sources (Fig. 1). At smolt, overall mortality was 17 % lower in fish fed diets supplemented 
with krill oil than those supplemented with soybean lecithin (average mortality, 4.02 ± 0.51 
vs. 4.72 ± 0.60 %, respectively), with both being significantly lower than fish fed the basal 
unsupplemented diet (5.42 ± 0.49 %) (Table 4). It should be noted that the group fed the 
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highest level of krill phospholipid were terminated on ethical grounds after the 10-20 g 
sample as examination of unexpected mortalities had shown some fish were showing a 
cestode infection and so all fish were culled on veterinary advice. Testing at the time and at 
termination of the trial revealed no other treatments were infected.  
 From first-feeding (900 ˚dpf) to ~1 g (1400 ˚dpf) weight increased with increasing 
phospholipid supplementation in both dietary phospholipid sources (Fig. 2A). Fish fed the 
krill phospholipid supplemented diets showed significantly higher mean weights than fish fed 
the respective soy lecithin supplemented diets, and this aspect was maintained throughout 
development although by smolt the only significant difference observed in final weight within 
respective phospholipid supplementation levels was at 2.6 % (Fig. 2E). All dietary groups, 
with the exception of the lowest level of soy lecithin supplementation (2.6 % phospholipid), 
achieved a significantly greater weight than fish fed the basal unsupplemented diet at 1 g. As 
development progressed (> 1990 ˚dpf, ≥ 2.5g, Figs. 2B-D) weight gain started to decrease in 
fish fed higher levels of dietary phospholipid. In fish fed the krill oil, the highest weight gain 
was consistently observed in fish fed 2.6 % phospholipid and higher inclusions showing a 
decreasing trend in weight, that became increasingly significant with development and 
inclusion level (Figs. 2B-D). In fish fed the soy lecithin, weight increased with increased 
inclusion levels up to 3.6 % phospholipid but then decreased in fish fed 4.2 % phospholipid 
(Figs. 2B-E). The pattern of fish weight observed at ~2.5 g (Fig. 2B), with the highest weights 
being attained in fish fed 2.6 % krill phospholipid and 3.6 % soy phospholipid, was 
maintained through development (Figs. 2C-E). This pattern was reflected in the higher overall 
SGR and TGC, and lower apparent FCR in fish fed these treatments when calculated at smolt 
(Table 3).  
   Therefore, there was a clear difference in the pattern of growth observed between fish fed 
the two PL preparations with fish fed krill oil showing better growth performance than those 
fed soy lecithin. However, irrespective of PL source, there was also a difference in the effects 
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of dietary PL on growth early in early development (measured at ~1 g) and that observed 
from 2.5 g onwards. This was highlighted by comparing SGR in the different developmental 
periods with SGR (0-2.5 g) showing significantly better growth performance in fish fed 2.6 % 
krill phospholipid and 3.6 % soy phospholipid compared to fish fed the basal diet, whereas 
there was no difference in SGR or TGC between these treatments when measured from 2.5 g 
to smolt (Fig. 3).  
 
3.2 Intestinal histology and steatosis 
At 2.5 g, mid-intestine enterocyte height did not differ significantly between any 
dietary treatment or phospholipid source (44.4 ± 1.5 µm, p = 0.492). However, intestinal 
steatosis was clearly observed in fish fed both the basal unsupplemented and the 2.6 % soy 
phospholipid diets with a prevalence of 20 % and 10 % of fish affected, respectively.	  Steatosis 
was characterized by several clear, variably sized, intracytoplasmic vacuoles in mostly apical 
enterocytes of the mid intestine (Fig. 4). No steatosis was observed in the intestine of 2.5 g 
fish fed any of the krill phospholipid-supplemented diets or in fish fed 3.2 % or higher levels 
of soy phospholipid. In addition, no steatosis was observed in the intestines of fish fed any of 
the dietary treatments at 10-20 g.  
 
3.3 Skeletal development and spinal deformity 
 The overall prevalence of radiological detectable spinal deformity was generally low 
in smolt fed all treatment groups, varying between 4 and 16 % (Fig. 5A). Highest prevalence 
was observed in fish fed the basal unsupplemented diet. There was no significant difference 
between any supplemented dietary group other than the 3.6 % krill phospholipid which had a 
significantly lower prevalence of deformity. However, there was a general trend of decreasing 
deformity with increasing krill phospholipid supplementation. In the soy phospholipid groups 
vertebral deformity was significantly reduced at 3.2 % PL and above compared to the 
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unsupplemented or 2.3 % soy PL diets. The mean number of deformed vertebra (dV) per 
deformed fish did not differ significantly between any dietary group other than the 3.6 % krill 
phospholipid group, which had a significantly lower number of dV than fish fed the basal and 
2.6 % krill phospholipid diets (Fig. 5B).  
    The predominant location of vertebral deformities was in the most cranial and caudal parts 
of the vertebral column in all dietary groups (Fig. 5C). The vertebrae most affected in these 
regions were v3 in R1 and v55 in R4 in fish fed either phospholipid source. There was also a 
higher (double) prevalence in these regions in fish fed soy phospholipid than fish fed krill 
phospholipid. Three predominant pathology types were observed, these being: decrease of 
intervertebral space (Type 1); compression (Types 2-5); and loss of symmetry due to dorsal or 
ventral shifting of the vertebra centre (Type 19). These three pathologies accounted for 32.2, 
42.4 and 23.7 %, respectively, of all deformity in fish fed the basal unsupplemented diet. The 
same pattern, with Types 2-5 predominating, was observed in fish fed krill phospholipid diets 
with the proportions being 27.9, 49.0 and 22.3 %. In contrast, in fish fed soy phospholipid the 
pathologies were more even distributed at 33.6, 32.4 and 31.5 %. 
 
3.4 Smoltification and seawater adaptation 
Saltwater challenge survival was 100 % in fish fed 2.6 % krill phospholipid from 300 
˚d (3635 ˚dpf) to 550 ˚d post winter solstice (Fig. 6). In contrast, fish fed 3.6 % krill 
phospholipid, and 2.6 and 3.6 % soy phospholipid showed significantly lower seawater 
challenge survival at 300 ˚d post winter solstice. Subsequent seawater challenges showed an 
improvement in survival in these three groups concomitant with increased body weight. At 
500 ˚d post winter solstice and beyond, all dietary groups returned a seawater challenge 
survival of 100 % (Fig. 6). Plasma chloride levels decreased with time in all dietary groups 
(191.5 ± 8.5 to 158.5 ± 9.2 mmol L-1), but did not differ significantly between krill and soy 
phospholipid supplemented groups (data not shown).  
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4. Discussion 
     Although it is well-known that the inclusion of intact phospholipids in the diet can 
improve growth, survival and development in early life stages of various freshwater and 
marine fish species (Coutteau et al., 1997), the only reports on phospholipid requirements in 
Atlantic salmon were a quarter of a century ago (Poston, 1990, 1991).  Therefore, the specific 
aims of the present study were to investigate the requirement for dietary phospholipid in 
Atlantic salmon and better define the level and time of requirement and, if possible, the 
relative importance of individual phospholipid classes. In addition to effects on growth and 
survival, the present study provided novel data on the effects of dietary phospholipid on 
intestinal steatosis, skeletal development and seawater adaptation in Atlantic salmon.  
       Before discussing in detail the relevant results of the present study it is necessary to be 
clear about what these were and how they relate, or not, to the aims of the study.  
1. Initially, at first feeding, fish fed krill oil had a significantly better growth rate than fish fed 
soy lecithin. Specifically, fish fed krill oil attained higher weights than fish fed soy lecithin at 
the equivalent phospholipid inclusion levels, and so this effect was not linked to dietary 
phospholipid content. Furthermore, as weight of fish at equivalent PC levels was also higher 
in fish fed krill oil, it was not related to the PC content.  
2. However, irrespective of whether from krill oil or soy lecithin, supplemental phospholipid 
to first feeding fry up to 2850 ˚dpf increased growth/weight over fry fed the basal diet and so 
there was an effect of dietary phospholipid. 
3. In fish fed krill oil, the highest weight was obtained in fish fed 2.6 % total phospholipid, 
whereas within fish fed soy lecithin a higher level total phospholipid was required (3.6 %) to 
give highest weight among the soy-fed fish. This difference between krill and soy lecithin, 
distinct to the overall difference noted in point 1, may be linked to the level of individual 
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phospholipid classes such as PC in the different phospholipid ingredients, and this was 
partially supported by the effects on intestinal steatosis and skeletal deformities.  
Therefore, point 1 above was an ingredient/raw material effect not related to the focus of the 
study, dietary phospholipid, and it complicated interpretation of the data. In particular it 
prevented further interpretation of the data in terms of individual phospholipid classes 
because, although the two phospholipid preparations were rather different in phospholipid 
class composition, the confounding raw material effect prevented identification of effects 
unequivocally due to phospholipid class. Precisely what was responsible is not known but 
krill meals are well-known have attractant/appetite stimulating properties. As waste feed was 
not able to be recovered at first feeding, fish were fed to excess and therefore it is likely the 
higher growth was due to increased feed intake in the krill oil fish. 
     Based on growth performance and survival data, Poston (1990, 1991) concluded that 
Atlantic salmon of initial weight up to 1.7 g showed a requirement for dietary phospholipid 
whereas fish of 7.5 g initial weight showed no requirement. In the present study, the 
numerical weights of fish at 1990 ˚dpf (approximately 1 g) increased in a graded manner with 
increasing phospholipid supplementation in fish fed both dietary phospholipid sources. In 
addition, survival at smolt was improved in fish fed supplementary dietary phospholipid. 
Further analyses of growth performance, specifically SGR, in the present study showed that 
the growth promoting effect of dietary phospholipid was observed in the period from first 
feeding to 2.5 g (2850 ˚dpf) and not from 2.5 g to smolt, indicating that the requirement for 
dietary phospholipid was restricted to early fry. Therefore, these basic data confirmed that 
Atlantic salmon have a requirement for dietary phospholipid in early development up to 
around 2850 ˚dpf although the precise time could be slightly earlier or later. In the previous 
studies on salmon, the dietary requirement for phospholipid appeared to decrease with 
development as the requirement was reportedly 6 % in 0.18 g fish (Poston, 1991), around 4 % 
in fish of 1.7 g, and not present in 7.5 g fish (Poston, 1990). 
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    The phospholipid level to satisfy dietary requirements in fish has been difficult to 
unequivocally establish due to the use of a wide range of phospholipid sources that can vary 
considerably both in phospholipid content and class composition (Tocher et al., 2008). As the 
present study was a long-term trial from first feeding to smolt using several inclusion levels, 
the use of purified phospholipids was not possible. However, in contrast to many studies, both 
the phospholipid sources (krill oil and soy lecithin) and the feeds were fully analysed so that 
the precise content and compositions were known. Therefore, we can be clear that the highest 
growth rate in early development was obtained with fish fed phospholipid at 2.6 % of diet 
when krill oil was supplemented and that final smolt weights were highest, and not different, 
between fish fed 2.6 % krill and 3.6 % soy phospholipid. These dietary percentages represent 
the sum of the four main glycerophospholipids, PC, PE, PS and PI.  
     In comparison, in the early studies of Poston (1990,1991), growth rate in salmon up to 1.7 
g was higher in fish fed diets supplemented with 4 - 6 % lecithin compared to fish fed an 
unsupplemented diet.  It should be noted that these data are actually reporting the levels of the 
lecithin products that were supplemented to the feeds, and not the actual phospholipid or 
glycerophospholipid levels. Indeed, different lecithins were used and their precise 
compositions were not reported, but some estimates of actual phospholipid and 
glycerophospholipid levels can be extrapolated from the data given in Poston (1990, 1991). 
Thus, the lecithins were both approximately 60 % polar lipid and so the total 
phospholipid/polar lipid in diets containing 4 - 6 % lecithin would have been around 2.4 – 3.6 
%, respectively. Furthermore, in the present study, total glycerophospholipid (PC+PE+PI+PS) 
accounted for around 70 % of the total polar lipids in the soybean lecithin used and, assuming 
similar proportions in the soy and soy/corn lecithins used in Poston (1990,1991), dietary 
inclusion levels of 4 and 6 % lecithin would actually equate to around 1.7 - 2.5 %  
(glycero)phospholipids. This is in the same range as found in the present study and so we can 
be confident that the dietary requirement for phospholipid in Atlantic salmon is at the lower 
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end of the spectrum of levels reported for fish species (Coutteau et al., 1997; Cahu et al., 
2003a,b; Tocher et al., 2008).  
      A further interesting result in the present study was that growth decreased in fish fed krill 
phospholipid at levels higher than 2.6 % at later times in development, and also decreased in 
fish fed the highest soy (above the ‘optimum’ of 3.6 % of diet). This was unexpected and 
largely unprecedented and so not fully understood. One hypothesis is that this is due to the 
fact that dietary phospholipids do not provide as much energy as triacylglycerols and this 
becomes important in later life stages (Bell and Koppe, 2011). Therefore, in the early life 
stages when there is a limitation in enterocyte metabolism, the role of intact dietary 
phospholipid, and especially PC, in promoting lipoprotein biosynthesis (Cole et al., 2012) 
and, consequently, export of dietary lipid from the intestine (Field and Mathur, 1995) is 
predominant and is manifested in improved growth. However, in later life stages, when there 
is no impairment of metabolism in enterocytes and dietary intact phospholipid has no or 
reduced role in promoting export of dietary lipid from the intestine (Mansbach, 2000), the 
relative energy contents of phospholipid and triacylglycerol become more important. 
Therefore, the more dietary lipid as phospholipid rather than triacylglycerol will tend to lower 
growth due to reduced energy content and so, at high phospholipid levels, well above any 
“requirement” level, dietary phospholipid can result in reduced growth. 
     The new data obtained on intestinal steatosis in the present study provided support for 
several ideas and hypotheses advanced for phospholipid requirements in fish. Firstly, the fact 
that intestinal steatosis was only observed in 2.5 g fish and not in any later developmental 
stages supports the conclusion that salmon only have a requirement for dietary intact 
phospholipid in the early fry stage. Secondly, however, it may also suggest an association 
with PC based on the fact that steatosis was only observed in 2.5g fish in those being fed the 
diets with the lowest level of PC, namely the basal diet (0.8 % PC) and the lowest level of soy 
supplementation (1.3 % PC).  All feeds with PC above this level (i.e. from 1.5 to 3.3 % PC) 
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showed no intestinal steatosis. These data support previous studies that showed intestinal 
steatosis induced in carp larvae fed phospholipid-deficient diets was prevented by dietary PC 
and, to a lesser extent, PI (Fontagné et al., 1998). Finally, the observation of steatosis in 
salmon enterocytes supported the hypothesis that dietary phospholipid was required for the 
efficient export of dietary lipid from the intestine. Previous studies showed that diets deficient 
in phospholipid could lead to lipid accumulation in intestinal enterocytes in fish larvae 
(Fontagné et al., 1998; Olsen et al., 1999; Salhi et al., 1999; Liu et al., 2002). Based on these 
studies it was suggested that dietary phospholipid was required for the efficient exportation of 
dietary lipid from enterocytes (Fontagné et al., 1998; Geurden et al., 1998a; Olsen et al., 
1999; Salhi et al., 1999). The mechanism was proposed to be associated with lipoprotein 
assembly, specifically the outer phospholipid “coat” and so the stimulating effects of 
phospholipids were due to early life stages of fish having limited ability to biosynthesise 
phospholipids de novo (Geurden et al., 1995, 1999; Coutteau et al., 1997; Fontagné et al., 
1998).  
    The precise mechanism of how dietary phospholipid and, specifically, PC affect intestinal 
lipoprotein synthesis is not entirely clear. In the intestinal cell line, CaCo-2, supplementary 
PC increased the secretion of triacylglycerol-rich lipoproteins (Mathur et al., 1996). It may be 
simply that PC is required for lipoprotein assembly as the phospholipid ‘coat’ of 
chylomicrons is predominantly PC, with only small amounts of sphingomyelin and PE (Field 
and Mathur, 1995). However, PC also affects the synthesis and secretion of the main 
apolipoproteins of chylomicrons, apolipoproteins B and A-I. Thus, PC increased the rate of 
apoB secretion whereas PE, PS and sphingomyelin did not (Field et al., 1994), and intestinal 
apoA-I synthesis was shown to be regulated by dietary PC in newborn swine (Wang et al., 
2001). Furthermore, in liver cells, phospholipid synthesis has been linked to the secretion of 
apoB-containing lipoproteins (Yao and Vance, 1989) and PC increased the secretion of 
newly-synthesized triacylglycerols (Field and Mathur, 1995). Therefore, there may be 
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biochemical mechanisms linking dietary phospholipid and, especially, PC, to lipoprotein 
synthesis and secretion. 
     Vertebral deformities at smolt assessed by x-ray radiography in this study showed a 
relatively low prevalence (4 - 16 %) in fish fed all diets, and are towards the lower end of 
those reported in Atlantic salmon (6.0 - 73.3 %, Fjelldal et al., 2007, 2009; Witten et al., 
2009). Deformities were predominantly located in the cranial trunk (R1) and tail fin (R4), 
consistent with other reports in S1+ unvaccinated smolts (Fraser et al., 2014). Furthermore, 
the pathology type, principally compressions, did not differ between dietary pospholipid 
source. However, although prevalence was low, there was a general decrease in spinal 
deformity with increasing dietary phospholipid in both krill and soy groups relative to fish fed 
the non-supplemented diet. Studies on the effects of dietary phospholipid on skeletal 
development in salmonids are somewhat limited compared to other fish species (Cahu et al., 
2003b). In rainbow trout, no beneficial effect of dietary phospholipid supplementation on 
malformations at any developmental stage (0.2 or 0.5 g) was reported, although it was noted 
there was a higher degree of ossification in fish fed phospholipid-supplemented diets than in 
fish fed phospholipid-free diets (Daprà et al., 2011). By contrast, in marine larvae and other 
freshwater species, it has been widely shown that increased dietary phospholipid reduced 
spinal malformation (Cahu et al., 2003b), and that PI in particular was predominantly 
associated with reduced deformities (Geurden et al., 1998b; Cahu et al., 2003a). The 
mechanism by which PI regulates skeletal development is not fully understood, but it may 
regulate calcium entry into the cell (Cahu et al., 2003a), which may be stimulating osteocalcin 
(BGP) production to promote bone mineralisation (Sandel et al., 2010).  
    However, the present data on salmon are not entirely consistent with those reported 
previously for the beneficial role of PI. In the case of fish fed the soy phospholipid diets, 
spinal deformity was highest in the base diet (~0.24 % PI, PC:PI ratio 3.4), reduced in fish fed 
the 2.6 % soy supplemented group (0.53 % PI, PC:PI of 2.5), and was lowest in the 3.2 - 4.2 
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% soy phospholipid diets (0.80 - 0.99 % PI, PC:PI of 1.8) and, therefore, was consistent with 
the malformation reducing effect of increasing dietary PI. In contrast, fish fed the krill PL 
diets where spinal deformity decreased with increasing krill oil inclusion, PI remained more 
or less constant at 0.21 - 0.26 %, whereas PC levels increased (1.3 to 3.3 %) and, therefore, 
the PC:PI ratio (8.4 to 13.1) also increased. Thus, PI level per se would not appear to be 
responsible for the reduction in deformity in the krill-supplemented diet. However, Coutteau 
et al. (1997) noted that the interactive importance of both PC and PI is not well understood, 
and suggested that relative importance of phospholipid classes could be species specific. 
Recently in both Atlantic cod (Gadus morhua) and gilthead seabream (Sparus aurata), it was 
indicated that both dietary PI levels and PC:PI ratio are important in reducing deformity levels 
in larvae and early juveniles while supporting optimal growth (Sandel et al., 2010; Hansen et 
al., 2011). In the case of sea bream a decreasing PC:PI ratio promoted growth, while lowered 
dietary PI increased jaw malformation yet, conversely, increasing PI (i.e. reduced PC:PI ratio) 
showed a trend towards increased spinal malformation, particularly in faster growing 
individuals. In the present study on salmon, the lowest krill supplemented group, 2.6 % 
phospholipid, was the fastest growing group but with the highest deformity level, yet 
corresponded to the lowest PC:PI ratio (8.4) and is thus consistent with the observations in sea 
bream. In contrast, soy phospholipid supplemented diets showed the opposite effect where 
deformity decreased with decreasing PC:PI ratio supporting the direct role of PI as the main 
dietary phospholipid contributing to the reduction in malformation. Sandel et al. (2010) 
propose that while high PI diets correlated well with high growth rate and reduced jaw 
deformity, the apparent upregulation of osteocalcin production may lead to over-
mineralisation of the skeleton. Collectively these findings suggest that there needs to be an 
effective PC:PI ratio to promote growth but minimise specific deformity within each species 
and, in light of the present study, may also be dependent on origin of the dietary phospholipid 
source. 
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   In conclusion, the present study confirmed that Atlantic salmon have a dietary 
requirement for intact phospholipid in early development. Fish fed the low phospholipid 
(unsupplemented) diet showed lowest growth and survival, highest level of spinal deformities 
and displayed intestinal steatosis. Supplementary phospholipid increased growth, improved 
survival, reduced spinal deformities and prevented steatosis. The data on growth and steatosis 
indicated that the requirement for dietary phospholipid was restricted to fish of up to 2850 
˚dpf (~2.5 g). In addition to providing new data characterising the phospholipid requirement 
of Atlantic salmon, a major aim of the present trial was to provide intestinal and liver samples 
for gene expression analyses. These ongoing studies aim to elucidate the molecular 
mechanism(s) of dietary phospholipid requirement and to define the genes/enzymes or 
pathways that may be deficient in early life stages, potentially limiting phospholipid/PC 
production in enterocytes that, as a consequence, constrains chylomicron production and 
export of dietary lipid from the intestine.      
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Figure Legends 
Fig. 1. Correlation between dietary phospholipid content (percentage of diet) and cumulative 
mortality from first feeding until smolt (percentage). The basal unsupplemented diet is 
represented by the black square and fish fed krill or soy phospholipids are represented by the 
closed and open circles. 
 
Fig. 2. Weight (g) of salmon fry and parr fed increasing dietary phospholipid (percentage of 
diet) at selected points during development. Fish were sampled at approximately 1 g (A, 1400 
˚day post fertilisation), 2.5 g (B, 1990 ˚dpf), 5 g (C, 2350 ˚dpf), 10-20 g (D, 2850 ˚dpf) and 
smolt (E, 3800 ˚dpf). Data are means ± SD (n = 2, i.e. per tank, 50 fish/tank). Different 
superscript letters indicate significant differences (p < 0.05) between treatments within each 
growth/developmental phase. 
 
Fig. 3. Effect of development and dietary phospholipid on specific growth rate (SGR) of 
salmon. SGRwt (% day-1) was determined in fry over the period from first feeding to 2.5 g, 
and in parr from 2.5 g to smolt. Different superscript letters indicate significant differences (p 
< 0.05) within each growth/developmental phase. Data are means ± SD (n = 2, i.e. per tank, 
50 fish/tank). Different superscript letters indicate significant differences (p < 0.05) between 
treatments within each growth/developmental phase. 
 
Fig. 4. Steatosis in intestine. Longitudinal paraffin embedded sections of mid-intestine 
(Alcian blue PAS staining, 40x), showing A) normal intestine of fish fed 2.6 % krill 
phospholipid, and B) intestine of fish fed the basal unsupplemented diet presenting enterocyte 
steatosis. Arrow is indicating several clear, variably sized, intracytoplasmic vacuoles in 
mostly apical enterocytes.  
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Fig. 5. Skeletal deformities determined in smolt. A) Prevalence of radiological deformed 
vertebra in Atlantic salmon smolts fed either krill oil or soy lecithin supplemented diets, B) 
Mean number deformed vertebrae per deformed fish, and C) Percentage localisation of 
deformed vertebrae along the vertebral column (v1-59). Superscripts denote significant 
differences between dietary groups. Data are means ± SEM (n = 2, i.e. per tank, 15 fish per 
tank). Different superscript letters indicate significant differences (p < 0.05) between 
treatments. 
 
Fig. 6. Effect of dietary phospholipid on smoltification as determined by change in survival 
following seawater challenge (35 ppt for 24hr). The broken line indicates point where 
smoltification would be expected to be complete (i.e. ~400 ˚day post winter solstice under 
ambient photoperiod). 
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Table 1. Inclusion levels (g/ Kg) of oil components in the nine experimental feeds 
                               
 
Target phospholipid level (percentage of diet) 
 
Base 
 
2.5 
 
3.0 
 
3.5 
 
4.0 
      Krill Soy   Krill Soy   Krill Soy   Krill Soy 
Krill oil 0 
 
26 0 
 
50 0 
 
76 0 
 
126 0 
Soybean lecithin 0 
 
0 24 
 
0 49 
 
0 73 
 
0 122 
Fish oil STD 18 75 
 
50 75 
 
25 75 
 
0 53 
 
0 4 
Rapeseed oil 51   50 26   51 1   50 0   0 0 
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Table 2. Proximate compositions (percentage of wet weight) and lipid class compositions (percentage of total lipid) of experimental feeds 
                             
 
 1.5 % PL  2.6 % PL  3.2 % PL  3.6 % PL  4.2 % PL    Base   Krill Soy   Krill Soy   Krill Soy   Krill Soy 
 Proximate composition 
             Protein 54.8 ± 0.4  55.2 ± 0.1 55.1 ± 0.4  55.4 ± 0.0 55.1 ± 0.1  55.5 ± 0.1 55.3 ± 0.3  56.4 ± 0.2 55.4 ± 0.3  Lipid 17.0 ± 0.6  17.8 ± 0.3 17.2 ± 0.8  17.6 ± 0.6 17.3 ± 1.0  17.3 ± 0.9 17.0 ± 0.2  16.8 ± 0.5 16.7 ± 0.7  Ash 8.4 ± 0.1  8.5 ± 0.1 8.4 ± 0.0  8.5 ± 0.1  8.6 ± 0.1  8.7 ± 0.1 8.8 ± 0.1  8.9 ± 0.1 9.1 ± 0.1  Moisture 5.6 ± 0.1  5.5 ± 0.1 5.9 ± 0.1  5.4 ± 0.1 6.1 ± 0.1  5.2 ± 0.2 5.9 ± 0.1  5.5 ± 0.2 5.4 ± 0.2  Lipid class composition 
             PC 4.8 ± 0.6   10.1 ± 0.5 7.3 ± 0.2  12.9 ± 1.3 8.4 ± 0.4  16.3 ± 0.8 9.1 ± 0.5  19.6 ± 1.0 10.8 ± 1.3  PE 2.7 ± 0.2  2.8 ± 0.1 4.4 ± 0.1  3.0 ± 0.2 5.9 ± 0.3  3.3 ± 0.3 6.1 ± 0.4  3.5 ± 0.4 7.3 ± 1.2  PI 1.4 ± 0.1  1.2 ± 0.2 3.1 ± 0.6  1.3 ± 0.1 4.7 ± 0.2  1.5 ± 0.2 5.0 ± 0.1  1.5 ± 0.0 5.9 ± 1.5  PS 0.1 ± 0.1  0.3 ± 0.1 0.4 ± 0.1  0.3 ± 0.2 0.5 ± 0.1  0.5 ± 0.1 0.6 ± 0.1  0.6 ± 0.4 0.7 ± 0.1  Total PL1 9.0 ± 0.4  14.4 ± 0.4 15.2 ± 0.4  17.5 ± 0.8 19.5 ± 0.5  21.6 ± 0.6 20.8 ± 0.5  25.2 ± 0.8 24.7 ± 1.3  PL (% diet)2 1.5  2.6 2.6  3.1 3.3  3.7 3.5  4.2 4.1  Tot. Polar3 18.4 ± 0.8  23.7 ± 0.6 27.7 ± 0.9  28.2 ± 0.5 34.6 ± 0.6  31.8 ± 0.2 37.8 ± 2.1  38.5 ± 0.8 47.1 ± 2.7  Tot. Neutral4 81.6 ± 0.8   76.3 ± 0.6 72.3 ± 0.9   71.8 ± 0.5 65.4 ± 0.6   68.2 ± 0.2 62.2 ± 2.1   61.5 ± 0.8 52.9 ± 2.7 
 Values are the averaged data for the 0.5, 0.8 and 1.1 mm feeds (with SD provided simply to illustrate variance between feeds) 
  PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinoslitol; PL, phospholipid; PS, phosphatidylserine; Tot., Total. 
 1Total of the glycerophospholipid classes (PC + PE + PI +PS) as percentage of total lipid; 2Total PL expressed as a percentage of diet; 3Total polar  
lipids including glycolipids, pigment material; 4Total neutral lipids, predominantly triacylglycerol but including sterols, free fatty acids and steryl 
esters. 
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Table 3. Fatty acid compositions (Percentage of total fatty acids) of experimental feeds supplemented with krill oil or soybean lecithin. 
                            
 1.5% PL  2.6 % PL  3.2 % PL  3.6 % PL  4.2 % PL 
  Base   Krill Soy   Krill Soy   Krill Soy   Krill Soy 
14:0 3.9 ± 0.3  4.0 ± 0.2 3.1 ± 0.1  3.8 ± 0.1 4.0 ± 0.1  4.9 ± 0.2 3.5 ± 0.2  8.4 ± 0.5 2.1 ± 0.2 
16:0 15.4 ± 1.0  15.0 ± 0.5 14.8 ± 0.2  14.6 ± 0.6 18.5 ± 0.2  16.1 ± 0.7 18.6 ± 0.5  22.2 ± 1.3 20.0 ± 1.0 
18:0 3.2 ± 0.4  2.7 ± 0.2 3.0 ± 0.2  2.5 ± 0.1 3.4 ± 0.2  2.3 ± 0.2 3.4 ± 0.1  2.3 ± 0.1 3.8 ± 0.3 
Total Saturates1 23.6 ± 1.7  22.7 ± 0.6 21.8 ± 0.4  21.8 ± 0.8 27.0 ± 0.3  24.2 ± 1.1 26.6 ± 0.7  33.6 ± 1.9 26.9 ± 1.3 
16:1n-7 3.9 ± 0.3  3.7 ± 0.2 3.2 ± 0.2  3.3 ± 0.1 4.2 ± 0.1  3.8 ± 0.3 3.7 ± 0.2  6.0 ± 0.3 2.1 ± 0.3 
18:1n-9 28.2 ± 1.6  27.7 ± 1.1 29.6 ± 2.0  32.3 ± 1.3 20.3 ± 1.3  27.9 ± 1.1 18.6 ± 1.3  13.9 ± 1.0 20.0 ± 1.4 
18:1n-7 2.9 ± 0.1  3.1 ± 0.0 2.7 ± 0.1  3.5 ± 0.1 2.7 ± 0.1  3.9 ± 0.0 2.5 ± 0.1  4.9 ± 0.1 2.2 ± 0.1 
20:1n-9 3.3 ± 1.0  2.7 ± 0.8 2.6 ± 0.6  1.8 ± 0.1 3.1 ± 0.7  1.4 ± 0.2 2.7 ± 0.5  1.1 ± 0.1 1.0 ± 0.1 
22:1n-11 3.9 ± 0.9  3.0 ± 0.7 3.0 ± 0.6  1.2 ± 0.1 4.0 ± 0.9  0.7 ± 0.1 3.3 ± 0.7  0.8 ± 0.0 1.0 ± 0.1 
Total Monoenes2 43.9 ± 1.1  41.9 ± 0.5 42.7 ± 1.0  43.2 ± 1.3 35.9 ± 0.4  38.9 ± 1.0 32.1 ± 0.9  28.2 ± 0.9 27.9 ± 1.8 
18:2n-6 13.3 ± 0.6  13.9 ± 0.3 18.4 ± 0.4  16.2 ± 0.5 18.3 ± 0.8  14.7 ± 0.5 23.2 ± 0.5  8.7 ± 0.7 34.0 ± 1.8 
20:4n-6 0.4 ± 0.0  0.4 ± 0.0 0.3 ± 0.0  0.3 ± 0.0 0.4 ± 0.0  0.3 ± 0.0 0.4 ± 0.0  0.4 ± 0.0 0.2 ± 0.0 
Total  n-6 PUFA3 14.2 ± 0.6  14.7 ± 0.3 19.1 ± 0.4  16.8 ± 0.5 19.2 ± 0.8  15.3 ± 0.5 24.0 ± 0.5  9.4 ± 0.7 34.5 ± 1.8 
18:3n-3 3.4 ± 0.3  3.7 ± 0.2 3.9 ± 0.2  4.3 ± 0.3 2.7 ± 0.0  3.8 ± 0.2 2.9 ± 0.1  1.6 ± 0.1 3.5 ± 0.2 
18:4n-3 1.2  ±  0.2  1.5 ± 0.0 1.1 ± 0.0  1.2 ± 0.1 1.3 ± 0.0  1.5 ± 0.1 1.3 ± 0.2  2.5 ± 0.1 0.6 ± 0.3 
20:4n-3 0.4 ± 0.1  0.4 ± 0.0 0.3 ± 0.0  0.2 ± 0.0 0.4 ± 0.0  0.2 ± 0.0 0.4 ± 0.0  0.3 ± 0.0 2.6 ± 0.3 
20:5n-3 5.1 ± 0.7  6.6 ± 0.4 4.2 ± 0.3  6.1 ± 0.3 5.2 ± 0.3  8.4 ± 0.4 4.8 ± 0.3  13.4 ± 1.1 2.6 ± 0.3 
22:5n-3 0.8 ± 0.2  0.7 ± 0.0 0.6 ± 0.0  0.4 ± 0.0 0.7 ± 0.1  0.4 ± 0.0 0.7 ± 0.1  0.6 ± 0.1 0.3 ± 0.0 
22:6n-3 6.5 ± 0.9  7.0 ± 0.4 5.5 ± 0.5  5.1 ± 0.4 6.5 ± 0.5  6.2 ± 0.2 6.3 ± 0.5  8.7 ± 0.7 3.7 ± 0.5 
Total n-3 PUFA4 17.5 ± 2.1  19.8 ± 0.7 15.7 ± 0.9  17.4 ± 1.0 17.0 ± 1.0  20.6 ± 0.7 16.5 ± 1.2  27.1 ± 2.0 10.8 ± 1.2 
Total PUFA5 32.5 ± 2.5   35.4  ± 0.6 35.4 ± 1.3   35.0 ± 1.6 37.1 ± 0.6   36.9 ± 0.9 41.3 ± 0.9   38.2 ± 1.5 45.8 ± 2.6 
Values are the averaged data for the 0.5, 0.8 and 1.1 mm feeds (with SD provided to illustrate variance between feeds). 
   PUFA, polyunsaturated fatty acids. 1Totals include14:0, 15:0, 20:0 and 22:0; 2Totals include 16:1n-9, 20:1n-11, 20:1n-722:1n-9 and 24;1n-9; 
 3Totals include 18:3n-6, 20:2n-6, and 22:5n-6; 4Totals include 20:3n-3; 5Totals include C16 
PUFA. 
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Table 4. Mortality, SGR, TGC and FCR from first feed to smolt 2	  
PL Level PL Origin Mortality % SGR TGC FCR 
1.5 % Base 5.42 ± 0.49 1.39 ± 0.12 1.00 ± 0.17 0.79 ± 0.13 
2.6 % Krill 
Soy 
3.92 ± 0.99 
4.86 ± 0.42 
1.45 ± 0.08 
1.34 ± 0.14 
1.09 ± 0.06 
0.92 ± 0.13 
0.78 ± 0.08 
0.86 ± 0.13 
3.2% Krill 
Soy 
4.57 ± 1.31 
5.50 ± 0.67 
1.42 ± 0.32 
1.41 ± 0.16 
1.03 ± 0.27 
1.03 ± 0.17 
0.84 ± 0.09 
0.89 ± 0.14 
3.6% Krill 
Soy 
3.57 ± 0.90 
4.22 ± 0.42 
1.39 ± 0.22 
1.43 ± 0.19 
0.99 ± 0.16 
1.05 ± 0.15 
0.84 ± 0.12 
0.78 ± 0.08 
4.2% Soy 4.26 ± 0.15 1.39 ± 0.10 0.98 ± 0.08 0.76 ± 0.09 
*  
*Data only until 10-15 g as the 4.2 % krill phospholipid treatment was terminated after this 3	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Fig. 3. 35	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Fig. 6. 45	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